The Structural Heart Disease Program your partners for advanced interventional cardiology Structural Heart Disease is a new branch of cardiology involving.

Slides:



Advertisements
Similar presentations
INTERVENTIONAL CARDIOLOGY AN OVERVIEW
Advertisements

ANNUAL CLINICAL SERVICES OVERVIEW Vaughan Pearce Joint Medical Director CoG Meeting 16 January 2008 (Agenda item 8)
The Nebraska Heart Institute Heart Hospital Influencing and Shaping the Future of Health Care.
MISSION To provide easy accessibility to the highest quality and state-of-the-art care for the prevention, treatment and on-going management of Cardiovascular.
Percutaneous Therapy of Pulmonic and Mitral Valve Disease Atman P. Shah MD FACC FSCAI Director, Coronary Care Unit Assistant Professor of Medicine The.
Trileaflet Aortic Valve. Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed.
CABG VS Multi Vessel PCI Hasanat Sharif MD FRCS Chief of Cardiorthoracic Surgery Aga Khan University Hospital.
Cardiovascular Symposium 2014 Care at the Crossroads Saturday September 20, :00 a.m. – 1:30 p.m. Avalon Manor 3550 E. Lincoln Highway Merrillville,
Practice of Critical Care in South Korea Gee Young Suh, MD Department of Pulmonary and Critical Care Medicine Samsung Medical Center SungKyunKwan University.
Wockhardt Hospitals A Journey of Excellence in Healthcare.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
New guidelines for CABG
Transhepatic venous cardiac catheterization
MODERN METHODS IN THE MANAGEMENT OF HEART DISEASES Animesh Mishra; MD, DM Associate Professor Department of Cardiology NEIGRIHMSShillong-12.
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
Department of Cardiology in 2009 Josef Kautzner, MD, PhD Head of the Department.
Pediatric Interventions Cardiac Catheterization and Valvuloplasty.
National AMI Information Call February 5, 2008 Patient Safety Initiative.
Professor Martin T Rothman Director Cardiac Research & Development Barts & The London NHS Trust London, England Professor Martin T Rothman Director Cardiac.
Cardiothoracic Surgery. Topics Valvotomy and valve replacement Open heart surgery and cardiac bypass surgery Correction of congenital heart diseases Heart.
Cardiovascular Imaging Module II Vincent Brinkman, MD and Sharon Roble, MD Division of Cardiology The Ohio State University College of Medicine.
Trancatheter Aortic Valve Implantation (TAVI)
Confidential. This presentation is provided for the recipient only and cannot be reproduced or shared without Tennova Healthcare, Inc.’s express consent.
Adult Cardiac Valve Disease Marvin D. Peyton, M.D. Thoracic and Cardiovascular Surgery University of Oklahoma Health Sciences Center.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Dr C Raghu Interventional Cardiologist
Detailed Profile Proposal for 2015/16 presented to the Cardiology Technical Committee Cardiology consultation and patology board – Workflow Definition.
Adult with operated congenital heart disease: what should we check for? January 15 th, h-17h30.
Yoav Dori, MD PhD The Children’s Hospital of Philadelphia
Cardiac Diagnostic Imaging Services Dr Andrew Wood UHW Cardiff 14 th July 2010.
HRG4: Impact on Arrhythmia Care Donna Elliott-Rotgans Cardiology Service Manager UCLH / The Heart Hospital.
Newer Methods for Heart Surgeries in India… World class success rates, economical costs Read on, to know more about the advantages.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Early Experiences with Developing a Percutaneous Valve Program in the US Kimberly A. Skelding MD FACC FAHA FSCAI Director Cardiovascular Research Interventional.
No conflicts of interest or financial ties to disclose.
EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.
CARDIOEMBOLIC STROKE Debasis Das, MD, FACC Interventional Cardiologist CHI St. Vincent Heart Clinic Arkansas April 25, 2015.
| rejuveindiameditour.com.
Cardiovascular system
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Cardiac Rehabilitation Part I
The Society for Cardiovascular Angiography & Interventions (SCAI) Foundation Charles E. Chambers, MD, FSCAI President Elect, Society for Cardiovascular.
The potential of Interventional radiology
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Conditions & Treatments Conditions Treatments Our experts cardiologist diagnose and treat patients with coronary artery disease, heart failure, valve.
Michael S. Kim, Adam R. Hansgen, John D. Carroll 
The Role of the Heart Team in the Cath Lab in 2017
Specialist Cardiologist at Sydney. Macquarie University Hospital Cardiology at Macquarie University Hospital, a team of specialist cardiologist, who diagnose.
Special Hospital for surgical diseases “Filip Vtori”, Skopje
Edematous syndrome. Differential diagnosis of edema of various etiologies (local - allergic, cardiovascular, inflammatory, general - circulatory insufficiency,
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
Panel Discussion: What Should Be the Optimal Design for Percutaneous Aortic Valve Therapy? Raoul Bonan, MD Institut de Cardiologie de Montreal.
One-stop Hybrid Cardiac Surgery
Adult Congenital Heart Disease Overview of the Population at Risk
Cardiac Cath NUR 422.
Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement  John Webb, MD, FRCPC, Josep Rodés-Cabau, MD, FRCPC, Stephen.
The potential of Interventional radiology
Patent Foramen Ovale and Stroke
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization  Manesh R. Patel, MD, FACC, Steven.
What does the future hold for interventional cardiology?
Vikas Singh, MD, Alex P. Rodriguez, MD, Parth Bhatt, MD, Carlos E
Cardiology Mikayla Anderson W1.
Postinfarction Ventricular Septal Defects: Towards a New Treatment Algorithm?  Simon Maltais, MD, MS, Reda Ibrahim, MD, Arsène-Joseph Basmadjian, MD, Michel.
Is TAVR performed at your institution?
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
Transcatheter aortic valve implantation combined with conventional heart surgery: Hybrid approach for complex cardiac pathologic features  Miralem Pasic,
Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.
Best Heart Surgeon In India Million of surgeries are done each year to correct heart problems among children and adults. Although there are more than a.
Historical Milestones and Progress in the Research on Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy  Josef Veselka, MD, PhD  Canadian.
Presentation transcript:

The Structural Heart Disease Program your partners for advanced interventional cardiology Structural Heart Disease is a new branch of cardiology involving catheter based treatment of heart conditions that used to be treatable only with open heart surgery. Yet, even with advancements in today’s technology, not all patients with the same condition are good candidates for the same procedure. The University of Miami Miller School of Medicine and UHealth – University of Miami Health System provide an array of advanced services to the South Florida community and beyond. Our multidisciplinary Structural Heart Disease program is a resource to you and your patients dealing with challenging cardiac issues. University of Miami Hospital has 5 dedicated suites for interventional cardiology, including a unique suite designed to combine minimally- invasive percutaneous cardiovascular interventions with cardiovascular surgical procedures. Our cardiac imaging program includes cardiac CT, Cardiac MR, 3D Transthoracic and Transesophageal echocardiography, and it is fully integrated with our advanced structural heart disease program. Yet our team is only half of the equation. We are only at our best with the partnership of the skilled and compassionate physicians who refer their patients to us for interventional care. Our Structural Cardiology Team Interventional Cardiology Carlos Alfonso, M.D. Mauricio Cohen, M.D. Eddy De Marchena, M.D. Alan Heldman, M.D. Claudia Martinez, M.D. Mauro Moscucci, M.D. William O’Neill, M.D. Juan Zambrano, M.D. Cardiac Surgery Didier De Cannier, M.D. Marco Ricci, M.D. Don Williams, M.D. Cardiac Imaging Martin Bilsker, M.D. Joel Fishman, M.D. Robert Hendel, M.D. Maureen Lowery, M.D. Melissa Tracy, M.D. Howard Willens, M.D. To access any of our services, or for urgent inquiries, call our Physician to Physician Cardiovascular Access Line (UMax) Figure: Percutaneous treatment of a mitral valve paravalvular leak. Using the transseptal approach, a glide wire has been advanced into the left ventricle across the mitral valve leak in preparation for closure.

Interventional Services at UHealth For the treatment of cardiovascular conditions and structural heart disease: Diagnostic catheterization (coronary and peripheral) Complex angioplasty and stenting (coronary and peripheral) Carotid artery stenting Alcohol septal ablation for hypertrophic cardiomyopathy Percutaneous closure of atrial septal defects and PFO Percutaneous closure of ventricular septal defects (post myocardial infarction) Mitral valvuloplasty Aortic valvuloplasty Percuataneous aortic valve replacement (investigational) Percuatenous closure of paravalvular leaks Direct left ventricular apical puncture Transseptal cardiac catheterization Atrial septostomy for pulmonary hypertension Tandem heart supported or Impella supported high risk PCI Stem cell therapy for ischemic and non ischemic cardiomyopathy (investigational) To access any of our services, or for urgent inquiries, call our Physician to Physician Cardiovascular Access Line (UMax) Catheter-based treatment of structural heart disease is rapidly evolving. As technology advances, and new treatment options become available, one thing remains the same: the need for interventionalists, cardiac surgeons, general cardiologists and cardiac imaging specialists to collaborate closely on the care of each patient. The University of Miami Cardiovascular Program offers one of the nation’s most advanced programs for the diagnosis and percutaneous treatment of a full spectrum of structural heart conditions. Unique procedures we offer are available at few other centers in the nation, and offer opportunities for patients with advanced or complex disease to be treated. CATH LAB EXPERTS We offer our referring partners this pledge: -To provide timely, thoughtful consultations with our lead physicians on any case in which you are considering an interventional solution on an as needed and expedited basis. - To provide you with direct access to our structural heart disease program for formal or informal consultations. - To expedite the scheduling of your patients for interventional procedures at UHealth. - To expedite any tests or treatments needed for your patients, and to minimize patients travel time and re-visits. - To provide you with a full report of their care and outcomes in an extremely timely manner. - To provide an integrated and multidisciplinary approach to complex conditions such as hypertrophic cardiomyopathy, valvular heart disease, paravalvular leaks or cryptogenic stroke. Respectfully yours, Mauro Moscucci, M.D., M.B.A. Clinical Vice Chairman, Department of Medicine Chief, Cardiovascular Division